How to build working AI models when you are short on training data: AI as part of the business transformation toolkit (Part 3)
The sights of Artificial Intelligence (AI) can be trained on almost any business problem that will benefit from automation. But what if training data for your problem is in short supply? In this blog, Simon Shakespeare shares a few tricks for training AI without reinventing the algorithmic wheel or by creating training data out of thin air.
New modes of drug action tackle intractable diseases
2018 was a busy one for the US Food and Drug Administration. Drug approvals hit a record high, with 59 novel drugs securing the agency’s permission to head to market. This included a number of drugs with modes of action that transcend the two main classes of drugs.
No pain, no gain: R&D challenges for the success of microneedle systems
Microneedle systems pose multidisciplinary R&D challenges—some because of and some despite the much smaller size of the needles involved. But microneedle systems also offer exciting new prospects for drug delivery and multiplex biomarker detection. This information could be used to guide personalised treatment or enable value-based healthcare.
The future of molecular diagnostics: Will isothermal amplification techniques steal PCR’s crown in the close-to-patient era?
PCR is still the go-to method in the molecular diagnostics industry but, with the rise of close-to-patient testing, isothermal amplification methods with their low power and potentially easier detection schemes look increasingly attractive.
4 Benefits Satellite Operators and their Customers gain from an Edge-Centric Approach to the Industrial IoT
In our concept paper "Satellite at the Edge", we extolled the virtues of an edge-centric approach to Satellite IoT. Having described the “what”, we now set out the “why” by outlining four major benefits and asking whether they primarily advantage satellite network operators or their customers.
AI – The Blinking Red Warning Light
In the second post of his series, Simon Shakespeare responds to a concern that AI might soon hit some long-anticipated roadblocks and finds reassurance in the many other AI tools still left in the engineer’s toolbox.
Why do I dream of electric sheep? Developing the next generation of consumer products with new technology
Designing and manufacturing next-generation consumer products requires a combination of market and technology insight - especially when new technology can now turn your product into a service offering.
Remote monitoring and telemedicine: a match made in digital health heaven?
It’s tempting to think that IoT infrastructure and AI make remote disease monitoring straightforward. But even when this is technically feasible, healthcare system innovation is necessary to make the most of opportunities created by digital health.
Layer-by-layer NDT for additive manufacturing: a new paradigm in quality assurance
Additive manufacturing (“AM” popularly called “3D printing”) is often seen as a way to produce unique parts, but a much less discussed, though generally more beneficial, feature of the technology is the “complexity-for-free” aspect.
Can we imagine a future of personalised medicine based on the analysis of lipids and carbohydrates?
DNA to RNA to protein – from this simple but powerful concept was born first biotechnology and then personalised medicine. But are we missing something? Can we imagine a future of personalised medicine based on the analysis of lipids and carbohydrates?